1. Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives
   H. Miles Prince et al, 2023, Annals of Hematology CrossRef
2. Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment
   Xin-Rui Zhang et al, 2022, Cancers CrossRef
3. Primary Cutaneous CD30-Positive Lymphoproliferative Disorders—Current Therapeutic Approaches with a Focus on Brentuximab Vedotin
   Tomasz Stein et al, 2024, Journal of Clinical Medicine CrossRef